SEALSQ Enters the Healthcare Industry Through IC’Alps, Delivering Custom Integrated Chip Solutions and Post-Quantum Protection for Next-Generation Medical Devices
Rhea-AI Summary
SEALSQ (NASDAQ: LAES) announced entry into the healthcare industry via its subsidiary IC’Alps, delivering custom medical ASICs combined with embedded post-quantum cryptography on December 11, 2025.
IC’Alps highlights include ultra-low-power analog and digital designs for wearable and implantable monitoring, integrated physiological sensing (ECG/EGM, SpO2, respiration, ICP), smart ultrasound probe ASICs, ISO13485 quality conformance, and secure elements paired with SEALSQ’s PQC and Secure Vault architecture to protect long-lived device data.
The offering targets long-term device lifecycles (10–20 years) with NIST‑recommended post-quantum algorithms to secure patient identity, device communications, telemedicine, and cloud AI workflows.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
While LAES was down 2.85% ahead of this news, key semiconductor peers like POET, NVEC, and AIP showed positive moves between 1.1% and
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Strategic investment | Positive | +7.7% | Investment in EeroQ to support “Quantum Made in USA” strategy and SEALQUANTUM program. |
| Dec 03 | Corporate strategy update | Positive | +7.8% | Strategic gathering outlining 2025 milestones, 2026/2030 vision and strong FY2025 guidance. |
| Dec 01 | Satellite launch | Positive | -6.5% | Successful WISeSat satellite launch with SpaceX to expand IoT and cybersecurity coverage. |
| Nov 25 | Product launch | Positive | +3.4% | QS7001 secure element achieving CNSA 2.0 compliance with hardware post-quantum cryptography. |
| Nov 24 | Leadership change | Positive | +10.1% | Appointment of Group AI Officer to drive AI integration across product lines. |
Recent positive strategic and product announcements have usually been followed by positive price reactions, with one notable divergence on a satellite launch update.
Over the past few weeks, SEALSQ has reported multiple strategic and technology milestones. On Nov 24, a new Group AI Officer appointment supported its AI integration plans. Subsequent news highlighted the QS7001 quantum-resistant secure element, a successful satellite launch with SpaceX, a strategic gathering outlining 2026/2030 vision and FY2025 revenue guidance of $17.5M–$20.0M, and a strategic investment in EeroQ. This healthcare-focused ASIC and post-quantum security announcement extends the same post-quantum and semiconductor themes into the medical device market.
Market Pulse Summary
This announcement details SEALSQ’s entry into healthcare via IC’Alps, combining custom medical ASIC design with post-quantum cryptographic protection for connected devices. It extends recent themes of quantum security and secure semiconductors into wearables, implantables, and advanced imaging. Investors may track execution in medical applications, adoption of NIST-aligned PQC algorithms in long-lifecycle devices, and how this new vertical complements earlier strategic moves in satellites, quantum partnerships, and AI-led product integration.
Key Terms
beamforming technical
AI-generated analysis. Not financial advice.
Geneva, Switzerland, Dec. 11, 2025 (GLOBE NEWSWIRE) --
SEALSQ Corp (NASDAQ: LAES), ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced its strategic entry into the healthcare industry through its subsidiary IC’Alps which is recognized for its excellence in designing custom integrated circuits (ASICs) for advanced medical devices. Through IC’Alps, SEALSQ is well positioned to accelerate healthcare innovation with ultra-low-power systems, physiological sensing, ultrasound technologies, secure data processing, and post-quantum cryptographic protection, an essential safeguard for the future of connected healthcare.
IC’Alps brings a proven track record in delivering ASICs tailored to the demanding requirements of medical environments. Drawing upon deep expertise and an unwavering commitment to excellence, IC’Alps develops custom chips that meet precise needs in performance, cost optimization, miniaturization, and extended product lifetime in full respect of ISO13485 quality standard.
Ultra-Low-Power Design for Wearable and Implantable Devices
Energy efficiency is pivotal for battery-powered wearables and implantables. Using advanced ultra-low-power design techniques, IC’Alps delivers state-of-the-art, highly energy-efficient implementation an important enabler of the digitalization of medical devices.
Discover our analog nanopower unipolar ECG/EGM readout for implantable and wearable devices.
Integrated Physiological Sensing for Comprehensive Monitoring
Sensor technologies are revolutionizing diagnostics and remote care. IC’Alps provides custom ASICs capable of integrating:
- Activity monitoring
- Heart rhythm
- Intracranial pressure measure
- Blood oxygenation
- Respiration rate
- Other vital signs
- Wireless connectivity when required
- Optimized regulators and power management functions
- Embedded processing
This enables smaller, smarter devices capable of continuous, precise patient monitoring.
Discover uVisia, a medical reference design for ultra-low-power vital signs monitoring
And many more to come.
The list of applications benefiting from specific integrated circuits that provide unmatched advantages is huge. IC’Alps is very active on other designs for medical devices dealing with Brain Computer Interface, as well as new generation smart ultrasound probes (2D arrays, pulsers for various transducers, complete acquisition chain including low-noise amplifiers, programmable gain amplifiers, beamforming, etc.).
Read the technical article: Ultrasound: how ASICs support the future of medical imaging?
Last but not least, the team is also involved in the ambitious Ze[US] France2030 project to make in real time the invisible visible in the human body.
Discover details on French government, Inserm foundation, Physical for Medicine Paris, and involved partners web sites and communications.
Post-Quantum Protection: A New Standard for Healthcare Cybersecurity
The healthcare industry faces an unprecedented cybersecurity challenge. With the rise of connected medical devices, long-term patient data retention, and cloud-based AI analysis, current encryption methods are becoming increasingly vulnerable—especially as quantum computing advances.
SEALSQ integrates Post-Quantum Cryptographic (PQC) algorithms directly into medical ASICs, ensuring long-term, future-proof protection for:
- Patient identity and biometric data
- Implantable and wearable device communications
- Telemedicine and remote monitoring infrastructure
- AI-driven diagnostics processed in the cloud
- Healthcare provider networks and hospital systems
SEALSQ’s PQC implementations, compliant with NIST-recommended algorithms, are designed to withstand both classical and quantum attacks. Healthcare devices with long operational lifetimes, often 10 to 20 years, require cryptographic resilience extending well beyond today’s standards. PQC integration ensures that even data intercepted today cannot be decrypted by tomorrow’s quantum adversaries.
This makes SEALSQ the first semiconductor and security provider to offer end-to-end post-quantum protection across the entire healthcare device lifecycle, from data acquisition to wireless transmission and cloud processing.
Ensuring Patient Data Protection with Secure Elements
Complementing PQC, IC’Alps is able to integrate dedicated security primitives and secure elements to protect sensitive medical data against alteration or unauthorized disclosure. Together with SEALSQ’s Secure Vault architecture and post-quantum keys, this forms the strongest security stack available for medical semiconductor design.
A Major Step for SEALSQ in Securing the Future of Connected Healthcare
By combining SEALSQ’s world-leading expertise in post-quantum cybersecurity and secure semiconductors with IC’Alps’ mastery in medical ASIC design, SEALSQ enters the healthcare industry with a highly differentiated, future-proof offering.
Carlos Moreira, CEO of SEALSQ noted, "Healthcare devices must now be designed for a world where quantum computing exists. By integrating post-quantum security directly into custom medical chips, SEALSQ and IC’Alps ensure long-term patient data protection and enable the next generation of safe, efficient, and intelligent medical technologies."
About SEALSQ:
SEALSQ is a leading innovator in Post-Quantum Technology hardware and software solutions. Our technology seamlessly integrates Semiconductors, PKI (Public Key Infrastructure), and Provisioning Services, with a strategic emphasis on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors designed to address the urgent security challenges posed by quantum computing. As quantum computers advance, traditional cryptographic methods like RSA and Elliptic Curve Cryptography (ECC) are increasingly vulnerable.
SEALSQ is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across a wide range of applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems. By embedding Post-Quantum Cryptography into our semiconductor solutions, SEALSQ ensures that organizations stay protected against quantum threats. Our products are engineered to safeguard critical systems, enhancing resilience and security across diverse industries.
For more information on our Post-Quantum Semiconductors and security solutions, please visit www.sealsq.com.
Forward-Looking Statements
This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include SEALSQ's ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; and the risks discussed in SEALSQ's filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC.
SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
| SEALSQ Corp. Carlos Moreira Chairman & CEO Tel: +41 22 594 3000 info@sealsq.com | SEALSQ Investor Relations (US) The Equity Group Inc. Lena Cati Tel: +1 212 836-9611 lcati@theequitygroup.com |
FAQ
What did SEALSQ (LAES) announce about entering healthcare on December 11, 2025?
How does IC’Alps address power needs for medical wearables and implantables?
What post-quantum protection does SEALSQ offer for medical devices (LAES)?
Which medical functions and device types does IC’Alps target with custom ASICs?
Does SEALSQ claim compliance with medical quality standards for its ASICs?
